OncoVanta Therapeutics, Inc.

OncoVanta Therapeutics, Inc. is a biotechnology company specializing in precision TCR-T cell therapies targeting mutant TP53-driven solid tumors, with an initial focus on pancreatic cancer. They develop innovative immunotherapies aimed at difficult-to-treat cancers.